Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


McWherter Charles Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Sold 21,746 shares @ $11.4669, valued at $249.4k
Exercised 10,404 options to buy @ $5, valued at $52k
Exercised 708 options to buy @ $5, valued at $3.5k
Exercised 236 options to buy @ $5, valued at $1.2k
Exercised 3,892 options to buy @ $5, valued at $19.5k
Exercised 6,506 options to buy @ $5, valued at $32.5k
07/19/2023 4 McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Sold 21,749 shares @ $11.4267, valued at $248.5k
Exercised 10,407 options to buy @ $5, valued at $52k
Exercised 708 options to buy @ $5, valued at $3.5k
Exercised 236 options to buy @ $5, valued at $1.2k
Exercised 3,892 options to buy @ $5, valued at $19.5k
Exercised 6,506 options to buy @ $5, valued at $32.5k
05/19/2023 4 McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Sold 21,749 shares @ $9.0757, valued at $197.4k
Exercised 10,407 options to buy @ $5, valued at $52k
Exercised 708 options to buy @ $5, valued at $3.5k
Exercised 236 options to buy @ $5, valued at $1.2k
Exercised 3,892 options to buy @ $5, valued at $19.5k
Exercised 6,506 options to buy @ $5, valued at $32.5k
01/27/2023 4 McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $7.8, valued at $2.3M
01/27/2022 4 McWherter Charles (Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 225,000 options to buy @ $2.94, valued at $661.5k
01/28/2021 4 McWherter Charles (Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 112,000 options to buy @ $5.78, valued at $647.4k
05/19/2020 4 McWherter Charles (SVP & Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 328,299 options to buy @ $4.05, valued at $1.3M
01/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2018 4 McWherter Charles (Chief Science Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $11.69, valued at $1.8M
11/06/2017 4 McWherter Charles (SVP & Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Bought 300 shares @ $8.67, valued at $2.6k
Bought 4,700 shares @ $8.668, valued at $40.7k
07/24/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/19/2016 4 McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Bought 3,000 shares @ $1.68, valued at $5k
01/28/2016 4 McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 54,000 options to buy @ $1.06, valued at $57.2k
05/19/2015 4 McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Bought 400 shares @ $3.14, valued at $1.3k
Bought 600 shares @ $3.169, valued at $1.9k
Bought 1,000 shares @ $3.161, valued at $3.2k
01/08/2015 4 McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $10, valued at $1M
01/08/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
12/27/2013 4 McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Disposed/sold 5,660 options to buy @ $39.75, valued at $225k
Granted 5,660 options to buy @ $5, valued at $28.3k
Disposed/sold 1,886 options to buy @ $15.9, valued at $30k
Granted 1,886 options to buy @ $5, valued at $9.4k
Granted 31,134 options to buy @ $5, valued at $155.7k
11/01/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy